Provided by Tiger Fintech (Singapore) Pte. Ltd.

Embecta Corp.

12.09
+0.09000.75%
Pre-market: 12.700.6100+5.05%05:02 EDT
Volume:931.03K
Turnover:11.19M
Market Cap:702.85M
PE:12.21
High:12.63
Open:11.34
Low:11.34
Close:12.00
Loading ...

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

GlobeNewswire
·
01 Apr

Undervalued Small Caps With Insider Action Across Regions In April 2025

Simply Wall St.
·
01 Apr

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Business Wire
·
11 Mar

Embecta Insider Ups Holding By 20% During Year

Simply Wall St.
·
01 Mar

Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

Insider Monkey
·
20 Feb

Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

GuruFocus.com
·
07 Feb

Embecta Keeps Quarterly Dividend at $0.15 Per Share, Payable March 14 to Stockholders of Record on Feb. 28

MT Newswires Live
·
06 Feb

Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business

Benzinga
·
06 Feb

Stock Track | Embecta Corp. Plummets 5.99% as Revenue Guidance Cut Despite Q1 Earnings Beat

Stock Track
·
06 Feb

Embecta Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Feb

Embecta's Fiscal Q1 Adjusted Earnings Rise, Revenue Declines

MT Newswires Live
·
06 Feb

Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Zacks
·
06 Feb

Embecta Q1 2025 Adj. EPS $0.65 Beats $0.44 Estimate, Sales $261.900M Beat $254.617M Estimate

Benzinga
·
06 Feb

Embecta Corp Outlook 2025 Adj EPS $2.70 - $2.90

THOMSON REUTERS
·
06 Feb

Embecta Corp Outlook 2025 Reported REV $1,075 Mln - $1,092 Mln

THOMSON REUTERS
·
06 Feb

BRIEF-Embecta Q1 Revenue USD 261.9 Million

Reuters
·
06 Feb

Embecta Q1 Dividend USD 0.15

THOMSON REUTERS
·
06 Feb

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

Zacks
·
23 Jan

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Zacks
·
23 Jan

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

Zacks
·
06 Jan